Early predictive marker in CLL - serum CD23 - CLL Support
Early predictive marker in CLL - serum CD23
You need to be a member of this community to see this post.
Read more about...
3 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Potential Early Drivers of Disease in Treatment-Naive CLL Identified
This study reinforces others regarding mutations that predict a short time to first treatment....
Advances in Targeted Therapy for R/R CLL OncLive videos & transcripts by Nirav Shah MD & Nicole Lamanna MD
Advances in Targeted Therapy for R/R CLL
(These OncLive presentations are intended for medical...
A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lym
Background: Current therapies for CLL/SLL have frequent toxicities, are non-curative, and several...
Physical activity and hematological malignancies... decreased risk...significant in CLL
Physical Activity (PA) and CLL ...large study
There was a decreased risk of hematologic...
An Early Look at When CAR-T Therapy Fails Patients With CLL
Not exactly an optimistic report.
Dr James Gerson, MD, - "Not a lot is known as to what happens in...
Related Posts
- Molecular Genetics and Prognosis in Younger Patients with CLL
Ibrutinib Use in the Real World for CLL- Overview of Autoimmune Cytopenias in CLL
- How Ibrutinib works over time
Autoimmune hemolytic anemia (AIHA), Immune thrombocytopenia (ITP) and other autoimmune complications and extranodal involvement in CLL
